Patents
Patents for C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
07/2004
07/08/2004WO2004056745A2 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
07/08/2004WO2004056744A1 Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
07/08/2004CA2508621A1 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
07/01/2004WO2004055000A1 Multifunctional cationic photoinitiators, their preparation and use
06/2004
06/29/2004US6756372 For therapy of autoimmune diseases, alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, crohn's disease, ulcerative colitis, multiple sclerosis, guillain-barre syndrome, psoriasis
06/29/2004CA2133089C Novel cyclic amino acids and derivatives thereof
06/24/2004WO2002092594A8 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
06/24/2004US20040122091 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
06/24/2004DE10249324A1 Polymerisationsfähige bicyclische Cyclopropanderivate und deren Verwendung zur Herstellung von Dentalmaterialien Polymerizable bicyclic cyclopropane derivatives and their use for the preparation of dental materials
06/23/2004EP1431298A1 Mannitol and glucitol derivatives
06/17/2004WO2004050609A1 Substituted ureas and carbamates
06/17/2004WO2004018414A3 Antibacterial agents
06/17/2004US20040116508 1-(N,N-bischloroethylaminoethoxy)-4-tert-butyldimethylsilyloxythioxanthone; administering first then sodium fluoride; tissue targeted therapy; administering in nontoxic, protodrug form which accumulates in neoplasm, followed by an activation drug
06/17/2004US20040116445 Substituted thioacetamides
06/17/2004US20040116405 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity
06/17/2004CA2507484A1 Substituted ureas and carbamates
06/15/2004US6750244 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
06/15/2004US6750228 Uncontrolled breakdown of connective tissue by metalloproteases is a feature of many pathological conditions
06/09/2004EP1426361A1 Novel composition containing a bi-cyclic compound and a glyceride
06/08/2004US6747149 Glucamine salts for treating hepatitis virus infections
06/03/2004WO2004045557A2 Novel lapachone compounds and methods of use thereof
06/03/2004CA2506340A1 Novel lapachone compounds and methods of use thereof
06/02/2004EP1424127A1 Thiopyryl cation and derivatives of same trapped in a zeolitic material
05/2004
05/27/2004WO2004029019A3 Compounds for the treatment of alzheimer’s disease
05/27/2004US20040102479 Novel benzopyran or thiobenzopyran derivatives
05/26/2004CN1151144C Benzopyans and benzothiopyrans as RAR selective retinoid agonists
05/21/2004WO2004041161A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
05/21/2004CA2502174A1 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
05/20/2004US20040097733 Bicyclic aromatic or heteroaromatic-amine compounds; Regulators of cell proliferation and differentiation; useful for treating skin related diseases; retinoid antagonist or retinoid inverse agonist-like biological activity
05/20/2004US20040097487 To inhibits matrix metalloprotease activity
05/19/2004EP1220849B1 Bicyclic compounds composition and method for stabilizing the same
05/19/2004CN1496975A Emodin derivative with anti-tumour activity
05/19/2004CN1150181C Substituted benzopyran analogs for treatment of inflammation
05/19/2004CN1150180C Diarylbenzopyran derivatives as cycloosygenase-2 inhibitors
05/13/2004WO2004024709A3 Xanthenyl cubane analogs with activity at the metabotropic glutamate receptors
05/12/2004EP1417198A2 Sulfonium salts as photoinitiators for radiation curable systems
05/12/2004EP1416936A1 Thiopyrane-4-ones as dna protein kinase inhibitors
05/12/2004EP0891346B1 Dihydrobenzofuran compounds useful as anti-inflammatory agents
05/12/2004CN1495181A Method for preparing cyclic oxazolidone containing sulfur and fluorine
05/12/2004CN1495160A I-substituted-1-aminomethyl-cycloalkane derivative (gabapentin analogs), its preparation and application for curing neuropathy
05/12/2004CN1149211C Benzoyl derivatives, method for producing them and their use as herbicids and plant growth regulators
05/11/2004US6734203 Fused imidazolium derivatives
05/06/2004WO2004037879A2 Monomers containing at least one biaryl unit and polymers and derivatives prepared therefrom
05/06/2004WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/06/2004US20040087632 Controlling metabolism of lipids, cholesterol
05/05/2004CN1494545A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors
05/05/2004CN1148346C Hydrazine derivs.
05/04/2004US6730697 For use as antiarrythmic medicaments with a cardioprotective component for prophylaxis of an infarction and therapy of infarction, and for treatment of angina pectoris
04/2004
04/29/2004WO2002078626A3 Therapeutic combinations for cardiovascular and inflammatory indications
04/29/2004US20040082601 Anti-inflammatory compounds
04/28/2004EP1413569A1 Bicyclic cyclopropane derivatives capable of polymerisation and their use in the preparation of dental materials
04/28/2004EP1042313B1 Benzopyran and benzothiopyran derivatives having retinoid antagonist like activity
04/28/2004EP0403618B2 Methyl esters of aldimino- or ketimino-oxy-ortho-tolylacrylic acid, manufacturing process and fungicides containing them
04/22/2004US20040077882 Polymerizable bicyclic cyclopropane derivatives and their use for the preparation of dental materials
04/21/2004EP1409456A2 Detection of transmembrane potentials by optical methods
04/21/2004EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
04/20/2004US6723736 For therapy inflammation, inflammatory diseases, immunologic diseases and other diseases mediated by tumor necrosis factor-alpha (tnf-alpha) and/or interleukin 6 or 10 and/or enzyme cyclooxygenase-2 (cox-2)
04/15/2004US20040072889 Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
04/14/2004EP1406891A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases
04/14/2004EP1406699A1 Antitumoral formulations of thioxanthenone
04/14/2004EP1406696A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
04/14/2004CN1145622C Substitated benzo heterocyclic compounds, process for their preparation and pharmaceutical compositions containing same
04/13/2004US6720319 Compounds useful as reversible inhibitors of cysteine proteases
04/13/2004CA2147123C Use of a cell membrane permeant calcium buffer for reducing injury of mammalian cells in vivo
04/08/2004WO2004029019A2 Compounds for the treatment of alzheimer’s disease
04/08/2004WO2004000889A3 Polymeric photoinitiators
04/08/2004US20040065866 Low viscosity; solubility at low temperature; low voltage display device
04/08/2004CA2500109A1 Compounds for the treatment of alzheimer's disease
04/06/2004US6716850 Non-nucleoside reverse transcriptase inhibitors
04/06/2004CA2223927C Detection of transmembrane potentials by optical methods
04/01/2004WO2004005478A3 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
04/01/2004US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes
03/2004
03/31/2004CN1143853C Preparing method for anti-viral compounds
03/30/2004US6713636 Having utility as fluorescent dyes
03/30/2004US6713580 Quaternary amino acids on solid supports
03/25/2004WO2004024709A2 Xanthenyl cubane analogs with activity at the metabotropic glutamate receptors
03/25/2004WO2004024679A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
03/25/2004WO2004024086A2 Compounds, compositions and methods
03/25/2004WO2004024081A2 Acetyl 2-hydroxy-1,3 diaminoalkanes
03/25/2004US20040059149 Method for the synthesis of compounds of formula 1 and derivatives thereof
03/25/2004US20040059145 Heterodiamondoids
03/25/2004US20040059133 Process for the production of substituted thioxanthones
03/25/2004CA2498248A1 Acetyl 2-hydroxy-1,3 diaminoalkanes
03/25/2004CA2497003A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
03/24/2004EP1400526A2 ((cyclo)alkyl substituted)- gamma -aminobutyric acid derivatives (=Gaba analogues), their preparation and their use in the treatment of neurological disorders
03/24/2004EP1140895B1 Thiopyran compounds as inhibitors of mmp
03/24/2004CN1142928C Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
03/18/2004WO2004021969A2 Non-nucleoside reverse transcriptase inhibitors
03/18/2004US20040053907 Cell adhesion inhibitors
03/18/2004CA2501924A1 Non-nucleoside reverse transcriptase inhibitors
03/17/2004CN1142158C Process to prepare cyclic-sulfur fluorine containing oxazolidinones
03/11/2004US20040049037 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
03/11/2004US20040048852 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
03/10/2004CN1481392A Surface-active photoinitiators
03/09/2004US6703422 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; alzheimer's disease; syndrome x; peroxisome proliferator activated receptor-associated disorder
03/04/2004WO2004018414A2 Antibacterial agents
03/04/2004WO2003078646A3 Aza-thioxanthenones with antitumor activity
03/03/2004EP1392683A1 SUBSTITUTED 4 i H /i -CHROMENES AND ANALOGS AS ACTIVATORS OFGASP ASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF
03/03/2004EP1392642A2 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
03/03/2004EP1392637A2 Modulators of peroxisome proliferator activated receptors
1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 48